Regulatory Amendment to Require Non-Medicinal Ingredient Labelling for Drugs in Canada

(Lexology – Penny Bonner et al., Ogilvy Renault LLP)

Canada has amended its Food and Drug Regulations to require non-medicinal ingredients (“NMIs”) to be included on the outer label of non-prescription drug products marketed in Canada.

The costs and administrative burden will be significant to both the pharmaceutical industry as well as the personal care product industry.

The NMI labelling requirement will be in force as of May 12, 2012.